1
|
Llorca CM, Berendzen KW, Malik WA, Mahn S, Piepho HP, Zentgraf U. The Elucidation of the Interactome of 16 Arabidopsis bZIP Factors Reveals Three Independent Functional Networks. PLoS One 2015; 10:e0139884. [PMID: 26452049 PMCID: PMC4599898 DOI: 10.1371/journal.pone.0139884] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2015] [Accepted: 09/18/2015] [Indexed: 12/22/2022] Open
Abstract
The function of the bZIP transcription factors is strictly dependent on their ability to dimerize. Heterodimerization has proven to be highly specific and is postulated to operate as a combinatorial mechanism allowing the generation of a large variety of dimers with unique qualities by specifically combining a small set of monomers; an assumption that has not yet been tested systematically. Here, the interaction pattern and the transactivation properties of 16 Arabidopsis thaliana bZIPs are examined in transiently transformed Arabidopsis protoplasts to deliver a perspective on the relationship between bZIP dimerization and function. An interaction matrix of bZIPs belonging to the C, G, H, and S1 bZIP groups was resolved by Bimolecular Fluorescent Complementation (BiFC) coupled to quantitative flow cytometric analysis, while an extensive GUS reporter gene assay was carried out to determine the effect of different bZIP pairs on the expression of four different known bZIP-targeted promoters. Statistical data treatment and complementary bioinformatic analysis were performed to substantiate the biological findings. According to these results, the 16 bZIPs interact in three isolated networks, within which their members dimerize non-specifically and exhibit a significant level of functional redundancy. A coherent explanation for these results is supported by in silico analysis of differences in the length, structure and composition of their leucine zippers and appears to explain their dimerization specificity and dynamics observed in vivo quite well. A model in which the bZIP networks act as functional units is proposed.
Collapse
Affiliation(s)
- Carles Marco Llorca
- Center for Plant Molecular Biology (ZMBP), University of Tübingen, Tübingen, Germany
| | | | - Waqas Ahmed Malik
- Biostatistics Unit, Institute of Crop Science, University of Hohenheim, Stuttgart, Germany
| | - Stefan Mahn
- Center for Plant Molecular Biology (ZMBP), University of Tübingen, Tübingen, Germany
| | - Hans-Peter Piepho
- Biostatistics Unit, Institute of Crop Science, University of Hohenheim, Stuttgart, Germany
| | - Ulrike Zentgraf
- Center for Plant Molecular Biology (ZMBP), University of Tübingen, Tübingen, Germany
- * E-mail:
| |
Collapse
|
2
|
Hu CM, Zhu J, Guo XE, Chen W, Qiu XL, Ngo B, Chien R, Wang YV, Tsai CY, Wu G, Kim Y, Lopez R, Chamberlin AR, Lee EYHP, Lee WH. Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism. Oncogene 2014; 34:1220-30. [PMID: 24662830 DOI: 10.1038/onc.2014.67] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2013] [Revised: 01/21/2014] [Accepted: 02/14/2014] [Indexed: 02/08/2023]
Abstract
Hec1 (highly expressed in cancer 1) or Nek2 (NIMA-related kinase 2) is often overexpressed in cancers with poor prognosis. Both are critical mitotic regulators, and phosphorylation of Hec1 S165 by Nek2 is required for proper chromosome segregation. Therefore, inactivation of Hec1 and Nek2 by targeting their interaction with small molecules represents an ideal strategy for tackling these types of cancers. Here we showed that new derivatives of INH (inhibitor for Nek2 and Hec1 binding) bind to Hec1 at amino acids 394-408 on W395, L399 and K400 residues, effectively blocking Hec1 phosphorylation on S165 by Nek2, and killing cancer cells at the nanomolar range. Mechanistically, the D-box (destruction-box) region of Nek2 specifically binds to Hec1 at amino acids 408-422, immediately adjacent to the INH binding motif. Subsequent binding of Nek2 to INH-bound Hec1 triggered proteasome-mediated Nek2 degradation, whereas the Hec1 binding defective Nek2 mutant, Nek2 R361L, resisted INH-induced Nek2 degradation. This finding unveils a novel drug-action mechanism where the binding of INHs to Hec1 forms a virtual death-trap to trigger Nek2 degradation and eventually cell death. Furthermore, analysis of the gene expression profiles of breast cancer patient samples revealed that co-elevated expressions of Hec1 and Nek2 correlated with the shortest survival. Treatment of mice with this kind of tumor with INHs significantly suppressed tumor growth without obvious toxicity. Taken together, the new INH derivatives are suitable for translation into clinical application.
Collapse
Affiliation(s)
- C-M Hu
- 1] Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA [2] Genomic Research Center, Academia Sinica, Taipei, Taiwan
| | - J Zhu
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - X E Guo
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - W Chen
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - X-L Qiu
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - B Ngo
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - R Chien
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - Y V Wang
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - C Y Tsai
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - G Wu
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - Y Kim
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - R Lopez
- Department of Chemistry, University of California, Irvine, CA, USA
| | - A R Chamberlin
- Department of Chemistry, University of California, Irvine, CA, USA
| | - E Y-H P Lee
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - W-H Lee
- 1] Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA [2] Genomic Research Center, Academia Sinica, Taipei, Taiwan [3] Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan
| |
Collapse
|